In recent years, innovative smart treatment options have emerged in GIST tumors that offer highly successful results with different mechanisms. Identification of relevant targeting mutations is necessary to determine these therapies. Comprehensive genetic analysis is recommended both at the beginning of treatment and in treatment resistance.